Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug trial for Kids' rare lung disease halted early

NCT ID NCT02615938

Summary

This study tested whether the drug hydroxychloroquine could help children with rare, chronic lung scarring diseases breathe easier. It was a small, early-phase trial that was terminated before completion. Researchers looked at whether starting or stopping the medication affected children's oxygen levels, breathing rates, and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Charité Berlin, Klinik für Pädiatrie

    Berlin, 13353, Germany

  • Justus-Liebig-Universität, Allgemeine Pädiatrie u. Neonatologie

    Giessen, Hesse, 35385, Germany

  • Klinik u. Poliklinik für Kinder- u. Jugendmedizin der Universität Leipzig

    Leipzig, Saxony, 04103, Germany

  • Klinikum der Universität München, Haunersches Kinderspital

    München, Bavaria, 80337, Germany

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, 30625, Germany

  • St. Joseph- und St. Elisabeth Hospital gGmbH

    Bochum, North Rhine-Westphalia, 44791, Germany

  • Uniklinikum Essen, Pädiatrische Pneumologie

    Essen, North Rhine-Westphalia, 45122, Germany

  • Universitätsklinik für Kinder- und Jugendmedizin Tübingen

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose

    Frankfurt am Main, Hesse, 60590, Germany

Conditions

Explore the condition pages connected to this study.